New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
14:01 EDTACORAcorda Therapeutics sees FY13 AMPYRA U.S. net sales $285M-$315M
Sees other revenue of $25M (FAMPYRA and Zanaflex), which includes $9.1M in amortized license revenue. Comment from slides that will be presented at the 31st Annual JP Morgan Healthcare Conference.
News For ACOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 12, 2014
08:13 EDTACORBoston Biotech to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use